Annual CFO
$1.37 B
-$222.00 M-13.96%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual cash flow from operations is currently $1.37 billion, with the most recent change of -$222.00 million (-13.96%) on 31 December 2023. During the last 3 years, it has risen by +$152.00 million (+12.50%). TEVA annual CFO is now -75.32% below its all-time high of $5.54 billion, reached on 31 December 2015.TEVA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$693.00 M
+$590.00 M+572.82%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly cash flow from operations is currently $693.00 million, with the most recent change of +$590.00 million (+572.82%) on 30 September 2024. Over the past year, it has increased by +$688.00 million (+13760.00%). TEVA quarterly CFO is now -60.45% below its all-time high of $1.75 billion, reached on 31 December 2014.TEVA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$1.86 B
+$688.00 M+58.90%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited TTM cash flow from operations is currently $1.86 billion, with the most recent change of +$688.00 million (+58.90%) on 30 September 2024. Over the past year, it has increased by +$699.00 million (+60.41%). TEVA TTM CFO is now -69.12% below its all-time high of $6.01 billion, reached on 30 June 2015.TEVA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.0% | +10000.0% | +60.4% |
| 3 y3 years | +12.5% | +31.0% | +175.8% |
| 5 y5 years | -44.1% | +113.2% | +221.7% |
TEVA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -14.0% | +71.4% | -41.5% | +577.9% | at high | +175.8% |
| 5 y | 5 years | -44.1% | +82.9% | -41.5% | +271.1% | at high | +311.5% |
| alltime | all time | -75.3% | >+9999.0% | -60.5% | +271.1% | -69.1% | +2034.0% |
Teva Pharmaceutical Industries Limited Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $693.00 M(+572.8%) | $1.86 B(+58.9%) |
| June 2024 | - | $103.00 M(-183.1%) | $1.17 B(-15.9%) |
| Mar 2024 | - | -$124.00 M(-110.5%) | $1.39 B(+1.5%) |
| Dec 2023 | $1.37 B(-14.0%) | $1.18 B(>+9900.0%) | $1.37 B(+18.2%) |
| Sept 2023 | - | $5.00 M(-98.5%) | $1.16 B(-31.7%) |
| June 2023 | - | $324.00 M(-323.4%) | $1.70 B(+13.5%) |
| Mar 2023 | - | -$145.00 M(-114.9%) | $1.49 B(-6.0%) |
| Dec 2022 | $1.59 B(+99.2%) | $973.00 M(+79.2%) | $1.59 B(+48.2%) |
| Sept 2022 | - | $543.00 M(+341.5%) | $1.07 B(+1.3%) |
| June 2022 | - | $123.00 M(-351.0%) | $1.06 B(-8.2%) |
| Mar 2022 | - | -$49.00 M(-110.7%) | $1.15 B(+44.6%) |
| Dec 2021 | $798.00 M(-34.4%) | $456.00 M(-13.8%) | $798.00 M(+18.6%) |
| Sept 2021 | - | $529.00 M(+142.7%) | $673.00 M(+49.2%) |
| June 2021 | - | $218.00 M(-153.8%) | $451.00 M(-10.9%) |
| Mar 2021 | - | -$405.00 M(-222.4%) | $506.00 M(-58.4%) |
| Dec 2020 | $1.22 B(+62.6%) | $331.00 M(+7.8%) | $1.22 B(-14.5%) |
| Sept 2020 | - | $307.00 M(+12.5%) | $1.42 B(-1.2%) |
| June 2020 | - | $273.00 M(-10.5%) | $1.44 B(+53.1%) |
| Mar 2020 | - | $305.00 M(-43.3%) | $941.00 M(+25.8%) |
| Dec 2019 | $748.00 M(-69.4%) | $538.00 M(+65.5%) | $748.00 M(+29.6%) |
| Sept 2019 | - | $325.00 M(-243.2%) | $577.00 M(-14.3%) |
| June 2019 | - | -$227.00 M(-302.7%) | $673.00 M(-36.6%) |
| Mar 2019 | - | $112.00 M(-69.5%) | $1.06 B(-56.6%) |
| Dec 2018 | $2.45 B(+9.9%) | $367.00 M(-12.8%) | $2.45 B(-16.7%) |
| Sept 2018 | - | $421.00 M(+159.9%) | $2.94 B(-11.3%) |
| June 2018 | - | $162.00 M(-89.2%) | $3.31 B(-7.6%) |
| Mar 2018 | - | $1.50 B(+74.2%) | $3.58 B(+61.1%) |
| Dec 2017 | $2.23 B(-42.8%) | $859.00 M(+8.1%) | $2.23 B(+52.8%) |
| Sept 2017 | - | $795.00 M(+82.8%) | $1.46 B(-31.4%) |
| June 2017 | - | $435.00 M(+219.9%) | $2.12 B(-19.9%) |
| Mar 2017 | - | $136.00 M(+51.1%) | $2.65 B(-31.9%) |
| Dec 2016 | $3.89 B(-29.8%) | $90.00 M(-93.8%) | $3.89 B(-28.2%) |
| Sept 2016 | - | $1.46 B(+51.7%) | $5.42 B(+7.3%) |
| June 2016 | - | $963.00 M(-30.0%) | $5.05 B(-9.3%) |
| Mar 2016 | - | $1.38 B(-14.8%) | $5.56 B(+0.4%) |
| Dec 2015 | $5.54 B(+8.1%) | $1.61 B(+47.8%) | $5.54 B(-2.4%) |
| Sept 2015 | - | $1.09 B(-26.1%) | $5.68 B(-5.5%) |
| June 2015 | - | $1.48 B(+9.3%) | $6.01 B(+7.6%) |
| Mar 2015 | - | $1.35 B(-22.7%) | $5.58 B(+8.9%) |
| Dec 2014 | $5.13 B(+58.4%) | $1.75 B(+23.0%) | $5.13 B(+22.3%) |
| Sept 2014 | - | $1.42 B(+35.2%) | $4.19 B(+30.5%) |
| June 2014 | - | $1.05 B(+17.3%) | $3.21 B(+5.9%) |
| Mar 2014 | - | $898.00 M(+10.0%) | $3.03 B(-6.3%) |
| Dec 2013 | $3.24 B(-29.2%) | $816.00 M(+83.8%) | $3.24 B(-19.0%) |
| Sept 2013 | - | $444.00 M(-49.3%) | $4.00 B(-13.1%) |
| June 2013 | - | $875.00 M(-20.6%) | $4.60 B(-6.4%) |
| Mar 2013 | - | $1.10 B(-30.1%) | $4.92 B(+7.6%) |
| Dec 2012 | $4.57 B(+10.6%) | $1.58 B(+50.5%) | $4.57 B(+3.4%) |
| Sept 2012 | - | $1.05 B(-12.0%) | $4.42 B(+14.7%) |
| June 2012 | - | $1.19 B(+57.5%) | $3.86 B(-3.3%) |
| Mar 2012 | - | $756.00 M(-47.1%) | $3.99 B(-3.5%) |
| Dec 2011 | $4.13 B | $1.43 B(+196.3%) | $4.13 B(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $482.00 M(-63.6%) | $3.81 B(-15.8%) |
| June 2011 | - | $1.32 B(+47.1%) | $4.52 B(+8.9%) |
| Mar 2011 | - | $900.00 M(-18.3%) | $4.15 B(+0.3%) |
| Dec 2010 | $4.14 B(+22.6%) | $1.10 B(-7.7%) | $4.14 B(+3.6%) |
| Sept 2010 | - | $1.19 B(+25.2%) | $3.99 B(+4.4%) |
| June 2010 | - | $954.00 M(+7.7%) | $3.82 B(+8.4%) |
| Mar 2010 | - | $886.00 M(-7.4%) | $3.53 B(+4.5%) |
| Dec 2009 | $3.37 B(+4.4%) | $957.00 M(-6.6%) | $3.37 B(-0.4%) |
| Sept 2009 | - | $1.02 B(+55.8%) | $3.38 B(+10.3%) |
| June 2009 | - | $658.00 M(-10.2%) | $3.07 B(-4.6%) |
| Mar 2009 | - | $733.00 M(-24.4%) | $3.22 B(-0.4%) |
| Dec 2008 | $3.23 B(+78.2%) | $969.00 M(+36.5%) | $3.23 B(+15.1%) |
| Sept 2008 | - | $710.00 M(-11.9%) | $2.81 B(+15.6%) |
| June 2008 | - | $806.00 M(+8.0%) | $2.43 B(+17.9%) |
| Mar 2008 | - | $746.00 M(+36.9%) | $2.06 B(+13.6%) |
| Dec 2007 | $1.81 B(-11.9%) | $545.00 M(+64.2%) | $1.81 B(-10.8%) |
| Sept 2007 | - | $332.00 M(-24.0%) | $2.03 B(-18.5%) |
| June 2007 | - | $437.00 M(-12.4%) | $2.49 B(+9.9%) |
| Mar 2007 | - | $499.00 M(-34.7%) | $2.27 B(+10.3%) |
| Dec 2006 | $2.06 B(+50.2%) | $764.40 M(-3.6%) | $2.06 B(+32.5%) |
| Sept 2006 | - | $792.80 M(+272.6%) | $1.55 B(+35.6%) |
| June 2006 | - | $212.80 M(-26.1%) | $1.15 B(-15.5%) |
| Mar 2006 | - | $288.00 M(+11.2%) | $1.36 B(-1.1%) |
| Dec 2005 | $1.37 B(+10.0%) | $259.10 M(-32.8%) | $1.37 B(-8.4%) |
| Sept 2005 | - | $385.30 M(-8.9%) | $1.50 B(-0.4%) |
| June 2005 | - | $422.90 M(+39.7%) | $1.50 B(+13.3%) |
| Mar 2005 | - | $302.70 M(-21.2%) | $1.32 B(+6.3%) |
| Dec 2004 | $1.25 B(+98.9%) | $384.10 M(-1.9%) | $1.25 B(+18.8%) |
| Sept 2004 | - | $391.40 M(+58.6%) | $1.05 B(+31.8%) |
| June 2004 | - | $246.80 M(+10.3%) | $795.40 M(+23.0%) |
| Mar 2004 | - | $223.70 M(+19.9%) | $646.70 M(+3.2%) |
| Dec 2003 | $626.60 M(+77.2%) | $186.50 M(+34.8%) | $626.60 M(+33.8%) |
| Sept 2003 | - | $138.40 M(+41.1%) | $468.40 M(+10.9%) |
| June 2003 | - | $98.10 M(-51.8%) | $422.40 M(-7.0%) |
| Mar 2003 | - | $203.60 M(+619.4%) | $454.30 M(+28.4%) |
| Dec 2002 | $353.70 M(+29.5%) | $28.30 M(-69.4%) | $353.70 M(-5.9%) |
| Sept 2002 | - | $92.40 M(-28.9%) | $375.75 M(+7.5%) |
| June 2002 | - | $130.00 M(+26.2%) | $349.46 M(+20.8%) |
| Mar 2002 | - | $103.00 M(+104.6%) | $289.18 M(+5.9%) |
| Dec 2001 | $273.15 M(+64.9%) | $50.35 M(-23.8%) | $273.15 M(+22.6%) |
| Sept 2001 | - | $66.12 M(-5.2%) | $222.80 M(+42.2%) |
| June 2001 | - | $69.71 M(-19.8%) | $156.68 M(+80.2%) |
| Mar 2001 | - | $86.97 M | $86.97 M |
| Dec 2000 | $165.63 M(+6.8%) | - | - |
| Dec 1999 | $155.06 M(+113.2%) | - | - |
| Dec 1998 | $72.71 M(-62.4%) | - | - |
| Dec 1997 | $193.60 M(-2947.1%) | - | - |
| Dec 1996 | -$6.80 M(-106.4%) | - | - |
| Dec 1995 | $106.30 M(+135.2%) | - | - |
| Dec 1994 | $45.20 M(+24.2%) | - | - |
| Dec 1993 | $36.40 M(+37.9%) | - | - |
| Dec 1992 | $26.40 M(+190.1%) | - | - |
| Dec 1991 | $9.10 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cash flow from operations?
- What is the all time high annual CFO for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CFO year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cash flow from operations?
- What is the all time high quarterly CFO for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CFO year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM cash flow from operations?
- What is the all time high TTM CFO for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CFO year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cash flow from operations?
The current annual CFO of TEVA is $1.37 B
What is the all time high annual CFO for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cash flow from operations is $5.54 B
What is Teva Pharmaceutical Industries Limited annual CFO year-on-year change?
Over the past year, TEVA annual cash flow from operations has changed by -$222.00 M (-13.96%)
What is Teva Pharmaceutical Industries Limited quarterly cash flow from operations?
The current quarterly CFO of TEVA is $693.00 M
What is the all time high quarterly CFO for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from operations is $1.75 B
What is Teva Pharmaceutical Industries Limited quarterly CFO year-on-year change?
Over the past year, TEVA quarterly cash flow from operations has changed by +$688.00 M (+13760.00%)
What is Teva Pharmaceutical Industries Limited TTM cash flow from operations?
The current TTM CFO of TEVA is $1.86 B
What is the all time high TTM CFO for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM cash flow from operations is $6.01 B
What is Teva Pharmaceutical Industries Limited TTM CFO year-on-year change?
Over the past year, TEVA TTM cash flow from operations has changed by +$699.00 M (+60.41%)